yingweiwo

AcLysValCit-PABC-DMAE-SW-163D

Cat No.:V35242 Purity: ≥98%
AcLysValCit-PABC-DMAE-SW-163D is part of the active antibody coupling molecule (drug-linker conjugates for ADC), which is made up of natural dual intercalator SW-163D and linker AcLysValCitPABC-DMAE coupling.
AcLysValCit-PABC-DMAE-SW-163D
AcLysValCit-PABC-DMAE-SW-163D Chemical Structure CAS No.: 2411007-69-5
Product category: Drug-Linker Conjugates for ADC
This product is for research use only, not for human use. We do not sell to patients.
Size Price
500mg
1g
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Product Description
AcLysValCit-PABC-DMAE-SW-163D is part of the active antibody coupling molecule (drug-linker conjugates for ADC), which is made up of natural dual intercalator SW-163D and linker AcLysValCitPABC-DMAE coupling.
AcLysValCit-PABC-DMAE-SW-163D (CAS#: 2411007-69-5) is a drug-linker conjugate for antibody-drug conjugates (ADCs). It has the molecular formula C85H113N19O22S2 and a molecular weight of 1817.07 g/mol. The compound consists of a natural bis-intercalator, SW-163D, conjugated via an AcLysValCit-PABC-DMAE linker. This linker is designed to be cleaved by proteases (e.g., cathepsin B) that are overexpressed in tumor cells, releasing the active payload. It is a valuable research tool for developing ADCs for cancer therapy.
Biological Activity I Assay Protocols (From Reference)
Targets
Traditional Cytotoxic Agents
The primary biological target of AcLysValCit-PABC-DMAE-SW-163D is DNA. The payload, SW-163D, is a natural bis-intercalator that binds to DNA and interferes with DNA replication and transcription, leading to cell death. The linker, AcLysValCit-PABC-DMAE, is designed to be stable in circulation and to release the payload specifically within tumor cells, where specific proteases are overexpressed. This targeted delivery approach aims to maximize efficacy while minimizing systemic toxicity.
ln Vitro
SW-163D is an antibiotic made of cyclodepsipeptides that was obtained from Streptomyces sp. Moreover, SW-163D demonstrates antitumor efficacy. PF06888667 is a strong, steady, and effective ADC made up of the bis-intercalator SW-163D conjugated to an engineered form of the anti-Her2 mAb, trastuzumab, catalyzed by transglutaminase, through a N-acetyl-lysine-valine-citrulline-p-aminobenzyl alcohol-N,N-dimethylethylenediamine (AcLysValCitPABC-DMAE) linker[1].
In vitro, AcLysValCit-PABC-DMAE-SW-163D is a drug-linker conjugate for ADCs. Its activity is dependent on its conjugation to a targeting antibody and subsequent internalization into target cells. The released payload, SW-163D, binds to DNA and induces cytotoxicity. The compound's antiproliferative activity is assessed using standard cell viability assays after conjugation to an appropriate antibody. The cleavage of the linker by proteases can be assessed using biochemical assays.
ln Vivo
Information regarding the in vivo activity of AcLysValCit-PABC-DMAE-SW-163D in animal models is limited. Its biological activity is primarily characterized as part of an ADC. The in vivo efficacy of ADCs containing this drug-linker conjugate is assessed in xenograft models. The compound would be administered intravenously, and tumor growth would be monitored. Further studies are needed to determine its pharmacokinetic properties and efficacy in animal models.
Enzyme Assay
The non-cellular enzyme or receptor binding assay for AcLysValCit-PABC-DMAE-SW-163D involves measuring the cleavage of the linker by proteases such as cathepsin B. This can be performed using a biochemical assay with purified cathepsin B and the drug-linker conjugate. The cleavage products are analyzed by HPLC or LC-MS/MS. The stability of the linker in plasma can also be assessed by incubating it in plasma and measuring the release of the payload over time.
Cell Assay
The in vitro cellular assay for AcLysValCit-PABC-DMAE-SW-163D involves conjugating the drug-linker to a targeting antibody and then treating cancer cell lines with the resulting ADC. Cell viability is assessed using standard assays such as MTT or CellTiter-Glo to determine the IC50. The internalization of the ADC is assessed by immunofluorescence microscopy. The release of the payload within cells is assessed by measuring the levels of free SW-163D using LC-MS/MS.
Animal Protocol
The in vivo animal experiment workflow for AcLysValCit-PABC-DMAE-SW-163D involves the use of xenograft models in immunodeficient mice. Cancer cells expressing the target antigen are injected subcutaneously. Once tumors form, the ADC is administered intravenously at various doses. Tumor growth is monitored by measuring tumor volume. The concentration of the ADC and released payload in tumor tissue and plasma is measured using LC-MS/MS.
References

[1]. Natural Product Bis-Intercalator Depsipeptides as a New Class of Payloads for Antibody-Drug Conjugates. Bioconjug Chem. 2018 Dec 13. doi: 10.1021/acs.bioconjchem.8b00843.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C85H113N19O22S2
Molecular Weight
1817.05
Exact Mass
1815.774
CAS #
2411007-69-5
PubChem CID
168012284
Appearance
Typically exists as solid at room temperature
Density
1.43±0.1 g/cm3(Predicted)
LogP
3.1
tPSA
604
Hydrogen Bond Donor Count
12
Hydrogen Bond Acceptor Count
27
Rotatable Bond Count
29
Heavy Atom Count
128
Complexity
4020
Defined Atom Stereocenter Count
14
SMILES
C[C@H]1C[C@]21C(OC[C@H](C(N[C@H](C(N([C@@H]1C(N([C@@]3(C(OC[C@H](C(N[C@H](C(N([C@@H]([C@@H](SC1)SC)C(N2C)=O)C)=O)C)=O)NC(C1=NC2C=CC=CC=2C=C1OC(=O)N(C)CCN(C)C(=O)OCC1C=CC(=CC=1)NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)C)CCCCN)=O)=O)C[C@@H]3C)C)=O)C)=O)C)=O)NC(C1C(=CC2C=CC=CC=2N=1)O)=O)=O
InChi Key
VQIBTARTHBHUSL-LXZQIUEZSA-N
InChi Code
InChI=1S/C85H113N19O22S2/c1-44(2)63(98-68(108)56(91-49(7)105)26-19-20-32-86)71(111)95-57(27-21-33-88-81(87)120)67(107)92-53-30-28-50(29-31-53)40-125-82(121)99(8)34-35-100(9)83(122)126-62-37-52-23-16-18-25-55(52)94-65(62)73(113)97-59-42-123-79(118)84(38-45(84)3)103(12)76(116)60-43-128-78(127-14)66(102(11)75(115)48(6)90-70(59)110)77(117)104(13)85(39-46(85)4)80(119)124-41-58(69(109)89-47(5)74(114)101(60)10)96-72(112)64-61(106)36-51-22-15-17-24-54(51)93-64/h15-18,22-25,28-31,36-37,44-48,56-60,63,66,78,106H,19-21,26-27,32-35,38-43,86H2,1-14H3,(H,89,109)(H,90,110)(H,91,105)(H,92,107)(H,95,111)(H,96,112)(H,97,113)(H,98,108)(H3,87,88,120)/t45-,46-,47-,48-,56-,57-,58+,59+,60-,63-,66+,78+,84-,85-/m0/s1
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 0.5503 mL 2.7517 mL 5.5034 mL
5 mM 0.1101 mL 0.5503 mL 1.1007 mL
10 mM 0.0550 mL 0.2752 mL 0.5503 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us